Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$0.2456
0.00351.45%
At close: Feb 11, 4:00 PM EST
$0.2505
0.00492.00%
After Hours: 4:23 PM EST
Comments
Loading...
Akari Therapeutics PLC (AKTX) Stock Price, Quote, News & History
AKTXNASDAQ
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Akari Therapeutics (AKTX) stock?
You can purchase shares of Akari Therapeutics (NASDAQ:AKTX) through any online brokerage.
Who are Akari Therapeutics (AKTX) competitors?
Other companies in Akari Therapeutics’s space includes: Alzamend Neuro Inc (NASDAQ:ALZN), Immuron Ltd (NASDAQ:IMRN), Bolt Biotherapeutics Inc (NASDAQ:BOLT), Sensei Biotherapeutics Inc (NASDAQ:SNSE) and AlphaTON Capital Corp (NASDAQ:ATON).
What is the forecast, or price target, for Akari Therapeutics (AKTX) stock?
Akari Therapeutics has a consensus price target of $2.53.
What is the current price for Akari Therapeutics (AKTX)?
The stock price for Akari Therapeutics (NASDAQ: AKTX) is $0.2505 last updated February 11, 2026 at 4:23 PM EST.
Does Akari Therapeutics (AKTX) pay a dividend?
There are no upcoming dividends for Akari Therapeutics.
When is Akari Therapeutics (NASDAQ:AKTX) reporting earnings?
Akari Therapeutics does not have any upcoming earnings scheduled.
Is Akari Therapeutics (AKTX) going to split?
There is no upcoming split for Akari Therapeutics.
What sector and industry does Akari Therapeutics (AKTX) operate in?
Akari Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
